Novel camphane-based anti-tuberculosis agents with nanomolar activity
Authors:
- Georgi StavrakovGeorgi Stavrakov
- Violeta ValchevaVVVioleta Valcheva
- Irena PhilipovaIPIrena Philipova
- Irini DoytchinovaIrini Doytchinova
- 1 December 2013
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 70, 372-379
Abstract
No abstract availableKeywords
Funding Information
- National Science Fund, Bulgaria
This publication has 19 references indexed in Scilit:
- Anti-AIDS agents 85. Design, synthesis, and evaluation of 1R,2R-dicamphanoyl-3,3-dimethyldihydropyrano-[2,3-c]xanthen-7(1H)-one (DCX) derivatives as novel anti-HIV agentsEuropean Journal of Medicinal Chemistry, 2012
- Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonistsBioorganic & Medicinal Chemistry Letters, 2009
- New anti-tuberculosis drugs in clinical trials with novel mechanisms of actionDrug Discovery Today, 2008
- Natural product growth inhibitors of Mycobacterium tuberculosisNatural Product Reports, 2006
- Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drugBritish Journal of Pharmacology, 2005
- Pharmacological treatment of headache using traditional Persian medicineTrends in Pharmacological Sciences, 2003
- Combinatorial Lead Optimization of [1,2]-Diamines Based on Ethambutol as Potential Antituberculosis Preclinical CandidatesJournal of Combinatorial Chemistry, 2003
- Intermolecular Accessibility: The Meaning of Molecular ConnectivityJournal of Chemical Information and Computer Sciences, 2000
- STRUCTURE‐ACTIVITY STUDIES LEADING TO ETHAMBUTOL, A NEW TYPE OF ANTITUBERCULOUS COMPOUND*Annals of the New York Academy of Sciences, 1966
- Configuration of Carbohydrates, Hydroxy-Acids and Amino-Acids: Configurations of Amino-Compounds and the Steric Course of DeaminationNature, 1950